Biovalve Technologies, Inc.
United StatesFDA applicant, unverified
- Devices
- 3
What Biovalve Technologies, Inc. makes
Biovalve Technologies, Inc. manufactures needle-free injection systems, including the BIOVALVE INSULIN DELIVERY SYSTEMS for subcutaneous medication delivery and the BIOVALVE MINI-JECT and MINIJECT (Model FG-01-001) for painless injections without traditional needles.
These devices are classified as Class II under FDA regulations and are authorised via the 510(k) pathway. The company is based in the United States.
Catalogue
Biovalve Insulin Delivery Systems (Bids) Ref K050971
Regimes: 510(k) Registry: 510(k)Biovalve Mini-Ject Needlefree Injector Ref K051985
Regimes: 510(k) Registry: 510(k)- Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Biovalve Technologies, Inc. have in the registry?
The registry currently lists 3 devices for Biovalve Technologies, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Biovalve Technologies, Inc.'s devices?
Among its 3 most recently registered devices, Biovalve Technologies, Inc. has devices listed in FDA 510(k) (3 devices).
What risk classes do Biovalve Technologies, Inc.'s devices fall under?
Among its 3 most recently registered devices, the classes recorded for Biovalve Technologies, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Biovalve Technologies, Inc. in the registry?
The most recently registered devices listed for Biovalve Technologies, Inc. include BIOVALVE INSULIN DELIVERY SYSTEMS (BIDS), BIOVALVE MINI-JECT NEEDLEFREE INJECTOR and BIOVALVE MINIJECT NEEDLE-FREE INJECTION SYSTEM, MODEL FG-01-001.